Showing 1 - 6 of 6 trials – Showing only trials currently accepting patients

• Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC)

  Stanford is currently accepting patients for this trial.

• Study of Kidney Tumors in Younger Patients

  Stanford is currently accepting patients for this trial.

• Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy

  Stanford is currently accepting patients for this trial.

• Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)

  Stanford is currently accepting patients for this trial.

• A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

  Stanford is currently accepting patients for this trial.

• A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

  Stanford is currently accepting patients for this trial.